ID: ALA4514455
Chembl Id: CHEMBL4514455
PubChem CID: 85954732
Max Phase: Preclinical
Molecular Formula: C19H25N3O2
Molecular Weight: 327.43
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)Oc1cc(C(=O)NCCN2CCCC2)c2ccccc2n1
Standard InChI: InChI=1S/C19H25N3O2/c1-14(2)24-18-13-16(15-7-3-4-8-17(15)21-18)19(23)20-9-12-22-10-5-6-11-22/h3-4,7-8,13-14H,5-6,9-12H2,1-2H3,(H,20,23)
Standard InChI Key: VEULWXVYDRMXAF-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 327.43 | Molecular Weight (Monoisotopic): 327.1947 | AlogP: 2.85 | #Rotatable Bonds: 6 |
| Polar Surface Area: 54.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 8.40 | CX LogP: 2.84 | CX LogD: 1.80 |
| Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.89 | Np Likeness Score: -1.67 |
| 1. Musharrafieh R, Zhang J, Tuohy P, Kitamura N, Bellampalli SS, Hu Y, Khanna R, Wang J.. (2019) Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)., 62 (8): [PMID:30912944] [10.1021/acs.jmedchem.9b00115] |
| 2. Kaur R, Kumar K.. (2021) Synthetic and medicinal perspective of quinolines as antiviral agents., 215 [PMID:33609889] [10.1016/j.ejmech.2021.113220] |
Source(1):
